NSG 522 Final Review Slides
NSG 522 Final Review Slides
NSG 522 Final Review Slides
FINAL EXAM
REVIEW INTRODUCTION TO
NSG 522: Applied Epidemiology and
EPIDEMIOLOGY
Biostatistics for Nursing Practice
Rush University, College of Nursing
CDC, 2006
1
11/29/18
DETERMINANTS
OF HEALTH
2
11/29/18
Health Behaviors
• Nutrition
• Physical activity
• Rest and relaxation MECHANISMS
• Tobacco use
• Alcohol use OF
• Illicit substance use
• Immunizations DISEASE CAUSATION
3
11/29/18
4
11/29/18
B – Biological, Behavioral
E – Environmental
I – Immunological
N – Nutritional
G – Genetic
S – Services, Social, Spiritual
Spectrum of Disease
• Describes the severity of disease
• Can vary from mild to fatal
SPECTRUM AND
NATURAL HISTORY
OF DISEASE
5
11/29/18
LEVELS OF
PREVENTION
6
11/29/18
COMMUNICABLE
DISEASES
7
11/29/18
Susceptible Host
• Susceptible host
- Immune status
- Overall health PREVENTION
- Nutritional status
AND CONTROL
OF INFECTION
8
11/29/18
• Quarantine
- Used for persons who have been exposed to a
contagious disease but may or may not become ill
9
11/29/18
HEALTH
SURVEILLANCE
10
11/29/18
11
11/29/18
• Numerator is always a part of the denominator • Numerator is always a part of the denominator
• Just a proportion multiplied by 100!!!
• Calculated as p= A e.g., 1/8 =.125 = 12.5%
A+B
• Calculated as P = A * 100
A+B
• Usually calculated as a decimal e.g., 1/8 =.125
Rates
• Frequency of an event in a population in a specified
period of time
CDC, 2006
12
11/29/18
13
11/29/18
Prevalence Prevalence
• Prevalence refers to the status of disease, not the onset • Prevalence is calculated as a proportion
Incidence Rate
• Incidence Rate =
Number of new cases of a disease in a specified time period
Time that each person was observed, totaled for all persons
EPIDEMIOLOGIC
• Also known as “”Person-Time Rate”
STUDY DESIGNS
• Most accurate estimate of risk
• More difficult to calculate
• Accounts for incomplete data
14
11/29/18
• Study of studies
Systematic reviews • Method used in Cochrane Reviews and AHRQ Reviews
Randomized controlled trials • Very powerful methodology
• Stringent criteria for inclusion in the analysis
Nonrandomized trials
• Quantitative analysis to combine and compare results of
Cohort studies the studies
Case-control studies
Cross-sectional studies
Case reports and case series
Opinion, experience, and theory
• Observational studies
• Retrospective
- Cohort studies
- Retrospective cohort studies
- Case-control studies
- Case-control studies
- Cross-sectional studies
• Cross-sectional
15
11/29/18
Cross-sectional studies
• A population is studied at a single point in time
• Risk is presented as a probability and can vary from 0 to 1.0 • Attributable Risk
- The amount of disease associated with a causative
Risk = Number of people who get the disease during a designated period factor in a specified population
Population of interest at the start of the designated time period
16
11/29/18
RR or OR < 1
- Risk or Odds in the exposed group is less than the
risk/odds in the non-exposed group
17
11/29/18
Confidence Intervals
• The exposure group (RR) or the cases (OR) are always
in the numerator and the comparison (non-exposed or
control) groups are always in the denominator
• Screening is used to promote detection of diseases in • Health screening activities are used to identify disease
their earliest stages, when treatment has the greatest during the preclinical (subclinical, presymptomatic, latent)
chance of working, in order to reduce morbidity and stage of disease
mortality
18
11/29/18
Sensitivity Sensitivity
• Probability that a person with the disease will test
People in the Population of Interest
positive for the disease (true positive)
Sensitivity = A / (A+C)
Specificity Specificity
• Probability that a person who does not have the disease People in the Population of Interest
will test negative for the disease (true negative)
Screening Test Disease Present No Disease
• The ability of the test to correctly identify those without
the disease B
Positive Test A False Positive
D
Negative Test C True Positive
Specificity = D / (B+D)
• Probability that a person who has a positive test actually People in the Population of Interest
has the disease
Screening Test Disease Present No Disease
C D
Negative Test False Negative True Negative
19
11/29/18
• Probability that a person who has a negative test does People in the Population of Interest
not have the disease
Screening Test Disease Present No Disease
C D
Negative Test False Negative True Negative
INVESTIGATION
OF AN TERMINOLOGY
OUTBREAK
20
11/29/18
Spread of Epidemics
• Common source
- Attributed to a specific source
- Point sources
- Intermittent sources
- Continuous sources STEPS IN AN
• Propagated INVESTIGATION
- Transmitted from person to person
• Mixed epidemic
- Starts with a common source
- Then spread by person-to-person contact
21
11/29/18
22
11/29/18
• Immunization programs
• Risk factor prevention
• Behavior change programs
Good Luck!
23